Schneeberger Daniel 4

Accession 0001104659-25-058955

CIK 0001664710other

Filed

Jun 11, 8:00 PM ET

Accepted

Jun 12, 4:51 PM ET

Size

16.6 KB

Accession

0001104659-25-058955

Form 4

Period: 2025-05-16

10% Owner

Transactions

Expiration
Put Option (obligation to buy)
2025-05-16−178→ 0 total(indirect: By LLC)
Exercise: $10.00From: 2025-04-03Exp: 2025-05-16→ Common Stock (17,800 underlying)
Expiration
Put Option (obligation to buy)
2025-05-16−836→ 0 total(indirect: By ADAR1 Partners, LP)
Exercise: $10.00From: 2025-04-03Exp: 2025-05-16→ Common Stock (83,600 underlying)
Expiration
Put Option (obligation to buy)
2025-05-16−300→ 0 total(indirect: By ADAR1 Partners, LP)
Exercise: $10.00From: 2025-02-27Exp: 2025-05-16→ Common Stock (30,000 underlying)

10% Owner

Transactions

Expiration
Put Option (obligation to buy)
2025-05-16−178→ 0 total(indirect: By LLC)
Exercise: $10.00From: 2025-04-03Exp: 2025-05-16→ Common Stock (17,800 underlying)
Expiration
Put Option (obligation to buy)
2025-05-16−300→ 0 total(indirect: By ADAR1 Partners, LP)
Exercise: $10.00From: 2025-02-27Exp: 2025-05-16→ Common Stock (30,000 underlying)
Expiration
Put Option (obligation to buy)
2025-05-16−836→ 0 total(indirect: By ADAR1 Partners, LP)
Exercise: $10.00From: 2025-04-03Exp: 2025-05-16→ Common Stock (83,600 underlying)

10% Owner

Transactions

Expiration
Put Option (obligation to buy)
2025-05-16−836→ 0 total(indirect: By ADAR1 Partners, LP)
Exercise: $10.00From: 2025-04-03Exp: 2025-05-16→ Common Stock (83,600 underlying)
Expiration
Put Option (obligation to buy)
2025-05-16−178→ 0 total(indirect: By LLC)
Exercise: $10.00From: 2025-04-03Exp: 2025-05-16→ Common Stock (17,800 underlying)
Expiration
Put Option (obligation to buy)
2025-05-16−300→ 0 total(indirect: By ADAR1 Partners, LP)
Exercise: $10.00From: 2025-02-27Exp: 2025-05-16→ Common Stock (30,000 underlying)

10% Owner

Transactions

Expiration
Put Option (obligation to buy)
2025-05-16−300→ 0 total(indirect: By ADAR1 Partners, LP)
Exercise: $10.00From: 2025-02-27Exp: 2025-05-16→ Common Stock (30,000 underlying)
Expiration
Put Option (obligation to buy)
2025-05-16−836→ 0 total(indirect: By ADAR1 Partners, LP)
Exercise: $10.00From: 2025-04-03Exp: 2025-05-16→ Common Stock (83,600 underlying)
Expiration
Put Option (obligation to buy)
2025-05-16−178→ 0 total(indirect: By LLC)
Exercise: $10.00From: 2025-04-03Exp: 2025-05-16→ Common Stock (17,800 underlying)

Footnotes (2)

[F1]As the investment manager of ADAR1 Partners, LP and as the sub-advisor of Spearhead Insurance Solutions IDF, LLC, ADAR1 Capital Management, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP and Spearhead Insurance Solutions IDF, LLC. As the general partner of ADAR1 Partners, LP, ADAR1 Capital Management GP, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP. As the manager of ADAR1 Capital Management, LLC and ADAR1 Capital Management GP, LLC, Mr. Schneeberger may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP and Spearhead Insurance Solutions IDF, LLC.
[F2]For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Documents

1 file

Keros Therapeutics, Inc.

CIK 0001664710

Entity typeother